OLIMEL N9E Emulsion for Infusion
Product details
Registration number: SIN16890P
Classification: Prescription Only
Active ingredients:
- (Compartment 1) Alanine
- (Compartment 1) Arginine
- (Compartment 1) Aspartic Acid
- (Compartment 1) Glutamic Acid
- (Compartment 1) Glycine
- (Compartment 1) Histidine
- (Compartment 1) Isoleucine
- (Compartment 1) Leucine
- (Compartment 1) Lysine Acetate eqv Lysine
- (Compartment 1) Magnesium Chloride Hexahydrate
- (Compartment 1) Methionine
- (Compartment 1) Phenylalanine
- (Compartment 1) Potassium Chloride
- (Compartment 1) Proline
- (Compartment 1) Serine
- (Compartment 1) Sodium Acetate Trihydrate
- (Compartment 1) Sodium Glycerophosphate, Hydrated
- (Compartment 1) Threonine
- (Compartment 1) Tryptophan
- (Compartment 1) Tyrosine
- (Compartment 1) Valine
- (Compartment 2) Calcium Chloride Dihydrate
- (Compartment 2) Glucose Monohydrate eqv Glucose Anhydrous
- (Compartment 3) Refined Olive Oil + Soya-bean Oil (80:20)
Strength:
- 8.24g/L
- 5.58g/L
- 1.65g/L
- 2.84g/L
- 3.95g/L
- 3.40g/L
- 2.84g/L
- 3.95g/L
- 4.48g/L
- 0.81g/L
- 2.84g/L
- 3.95g/L
- 2.24g/L
- 3.40g/L
- 2.25g/L
- 1.50g/L
- 3.67g/L
- 2.84g/L
- 0.95g/L
- 0.15g/L
- 3.64g/L
- 0.52g/L
- 110.0g/L
- 40g/L
Dosage form: EMULSION
Route: INTRAVENOUS
Registrant: BAXTER HEALTHCARE (ASIA) PTE LTD
ATC code: B05BA10
HSA approval date: 20 October 2023
Manufacturer(s):
- Ajinomoto Health & Nutrition North America Inc. (Intermediate)
- Baxter S.A
Manufacturing country/countries: UNITED STATES; BELGIUM
What are the HSA registration number and classification for OLIMEL N9E Emulsion for Infusion?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16890P
Classification: Prescription Only
What active ingredients and strength are recorded for OLIMEL N9E Emulsion for Infusion?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- (Compartment 1) Alanine
- (Compartment 1) Arginine
- (Compartment 1) Aspartic Acid
- (Compartment 1) Glutamic Acid
- (Compartment 1) Glycine
- (Compartment 1) Histidine
- (Compartment 1) Isoleucine
- (Compartment 1) Leucine
- (Compartment 1) Lysine Acetate eqv Lysine
- (Compartment 1) Magnesium Chloride Hexahydrate
- (Compartment 1) Methionine
- (Compartment 1) Phenylalanine
- (Compartment 1) Potassium Chloride
- (Compartment 1) Proline
- (Compartment 1) Serine
- (Compartment 1) Sodium Acetate Trihydrate
- (Compartment 1) Sodium Glycerophosphate, Hydrated
- (Compartment 1) Threonine
- (Compartment 1) Tryptophan
- (Compartment 1) Tyrosine
- (Compartment 1) Valine
- (Compartment 2) Calcium Chloride Dihydrate
- (Compartment 2) Glucose Monohydrate eqv Glucose Anhydrous
- (Compartment 3) Refined Olive Oil + Soya-bean Oil (80:20)
Strength:
- 8.24g/L
- 5.58g/L
- 1.65g/L
- 2.84g/L
- 3.95g/L
- 3.40g/L
- 2.84g/L
- 3.95g/L
- 4.48g/L
- 0.81g/L
- 2.84g/L
- 3.95g/L
- 2.24g/L
- 3.40g/L
- 2.25g/L
- 1.50g/L
- 3.67g/L
- 2.84g/L
- 0.95g/L
- 0.15g/L
- 3.64g/L
- 0.52g/L
- 110.0g/L
- 40g/L
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for OLIMEL N9E Emulsion for Infusion?
According to the HSA dataset updated 7 August 2026:
Dosage form: EMULSION
Route: INTRAVENOUS
Who is the recorded registrant for OLIMEL N9E Emulsion for Infusion?
According to the HSA dataset updated 7 August 2026:
Registrant: BAXTER HEALTHCARE (ASIA) PTE LTD
Which manufacturers and countries are listed for OLIMEL N9E Emulsion for Infusion?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Ajinomoto Health & Nutrition North America Inc. (Intermediate)
- Baxter S.A
Manufacturing country/countries: UNITED STATES; BELGIUM
Where can I look up OLIMEL N9E Emulsion for Infusion in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16890P or the exact product name OLIMEL N9E Emulsion for Infusion. The general register link does not preselect this product.
What are the source dates for this OLIMEL N9E Emulsion for Infusion record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this OLIMEL N9E Emulsion for Infusion record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16890P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)